1. Home
  2. CRNX vs NCNO Comparison

CRNX vs NCNO Comparison

Compare CRNX & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • NCNO
  • Stock Information
  • Founded
  • CRNX 2008
  • NCNO 2011
  • Country
  • CRNX United States
  • NCNO United States
  • Employees
  • CRNX N/A
  • NCNO N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • NCNO Computer Software: Prepackaged Software
  • Sector
  • CRNX Health Care
  • NCNO Technology
  • Exchange
  • CRNX Nasdaq
  • NCNO Nasdaq
  • Market Cap
  • CRNX 2.8B
  • NCNO 3.1B
  • IPO Year
  • CRNX 2018
  • NCNO 2020
  • Fundamental
  • Price
  • CRNX $29.20
  • NCNO $27.47
  • Analyst Decision
  • CRNX Strong Buy
  • NCNO Buy
  • Analyst Count
  • CRNX 8
  • NCNO 16
  • Target Price
  • CRNX $74.86
  • NCNO $31.33
  • AVG Volume (30 Days)
  • CRNX 806.6K
  • NCNO 1.4M
  • Earning Date
  • CRNX 08-07-2025
  • NCNO 08-26-2025
  • Dividend Yield
  • CRNX N/A
  • NCNO N/A
  • EPS Growth
  • CRNX N/A
  • NCNO N/A
  • EPS
  • CRNX N/A
  • NCNO N/A
  • Revenue
  • CRNX $760,000.00
  • NCNO $556,707,000.00
  • Revenue This Year
  • CRNX $409.34
  • NCNO $9.70
  • Revenue Next Year
  • CRNX $773.02
  • NCNO $8.80
  • P/E Ratio
  • CRNX N/A
  • NCNO N/A
  • Revenue Growth
  • CRNX N/A
  • NCNO 13.39
  • 52 Week Low
  • CRNX $24.10
  • NCNO $18.75
  • 52 Week High
  • CRNX $62.53
  • NCNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 37.84
  • NCNO 39.36
  • Support Level
  • CRNX $27.60
  • NCNO $27.00
  • Resistance Level
  • CRNX $31.50
  • NCNO $28.09
  • Average True Range (ATR)
  • CRNX 1.21
  • NCNO 0.79
  • MACD
  • CRNX -0.33
  • NCNO -0.49
  • Stochastic Oscillator
  • CRNX 9.89
  • NCNO 9.60

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

Share on Social Networks: